Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
  1. 4 Planned sale Chief Operating Officer sold 7,514 shares at an average $31.82 ($239,123)
  2. 4 Open-market sale Director sold 40,000 shares at an average $35.05 ($1,401,973)
  3. 4 Open-market sale Director sold 15,000 shares at $35.07 ($526,001)
  4. 4 Planned sale Chief Financial Officer sold 20,000 shares at $35.05 ($701,092)
  5. 4 Planned sale Chief Operating Officer sold 10,000 shares at $34.05 ($340,458)
  6. 4 Planned sale Chief Operating Officer sold 5,000 shares at an average $30.53 ($152,632)
  7. 4 Planned sale Kelsey Stephen Michael sold 33,332 shares at an average $30.80 ($1,026,481)
  8. 4 Planned sale General Counsel sold 1,500 shares at $26.02 ($39,030)
  9. 4 Open-market sale Kelsey Stephen Michael sold 2,102 shares at $24.89 ($52,321)
  10. 4 Open-market sale Chief Operating Officer sold 2,102 shares at $24.89 ($52,321)
  11. 4 Open-market sale Chief Financial Officer sold 1,249 shares at $24.89 ($31,089)
  12. 4 Open-market sale General Counsel sold 1,239 shares at $25.14 ($31,148)
  13. 4 Grant or award Director acquired 5,200 shares (grant or award)
  14. 4 Grant or award Director acquired 5,200 shares (grant or award)
  15. 4 Grant or award Director acquired 5,200 shares (grant or award)
  16. 4 Grant or award Director acquired 5,200 shares (grant or award)
  17. 4 Grant or award Director acquired 5,200 shares (grant or award)
  18. 4 Grant or award Director acquired 5,200 shares (grant or award)
  19. 4 Grant or award Director acquired 5,200 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 12 of 21 · 414 filings